Pfizer settles EpiPen price hike lawsuits for $345M
Pfizer has agreed to pay $345 million as part of a settlement related to a 5-year-old lawsuit over the company’s price hikes on the lifesaving EpiPen.
Plaintiffs across the country raised concerns over the price of the autoinjector 2-pack, which they said spiked from about $100 in 2007 to $608 in 2016 — an increase of over 600%.
“Were the price increases attributable to market conditions, increases in manufacturing costs, or shortages in the supply of epinephrine? Absolutely not. They were driven solely by unaccountable executives and companies who sought to profit off of human misery and fear,” the consolidated class action complaint from 2017 alleged.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.